VISIGLIDE: payments to doctors
Payments that named VISIGLIDE as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2M
- Providers
- 958
- Transactions
- 2,669
- Average per transaction
- $742
The per-transaction average — $742 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 958 providers the average total is $2,067, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Olympus Corporation Of The Americas | $1,571,989 | 79.4% |
| Olympus America Inc. | $401,378 | 20.3% |
| Olympus Latin America, Inc. | $6,555 | 0.3% |